COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34 Application WO-2023077042-A1 World Intellectual Property Organisation (WIPO) 04 May 2023
COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34 Application WO-2023076995-A1 World Intellectual Property Organisation (WIPO) 04 May 2023
COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34 Application WO-2023076971-A1 World Intellectual Property Organisation (WIPO) 04 May 2023
COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34 Application WO-2023076970-A1 World Intellectual Property Organisation (WIPO) 04 May 2023
O-GLCNACASE (OGA) INHIBITOR COMBINATION THERAPY Application WO-2023070064-A1 World Intellectual Property Organisation (WIPO) 27 Apr 2023
ANTI-AMYLOID BETA ANTIBODIES AND USES THEREOF Application WO-2022251048-A1 World Intellectual Property Organisation (WIPO) 01 Dec 2022
ANTI-AMYLOID BETA ANTIBODIES AND USES THEREOF Application WO-2022192636-A1 World Intellectual Property Organisation (WIPO) 15 Sep 2022
ANTI-N3PGLU AMYLOID BETA ANTIBODIES AND USES THEREOF Application WO-2022192639-A2 World Intellectual Property Organisation (WIPO) 15 Sep 2022
ANTI-N3PGLU AMYLOID BETA ANTIBODIES AND USES THEREOF Application WO-2022150735-A1 World Intellectual Property Organisation (WIPO) 14 Jul 2022